338
Views
7
CrossRef citations to date
0
Altmetric
Review

Tricuspid regurgitation: when is it time for surgery?

ORCID Icon, ORCID Icon & ORCID Icon
Pages 47-59 | Received 05 Sep 2020, Accepted 19 Nov 2020, Published online: 20 Jan 2021

References

  • Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(22): 2438–2488.
  • Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2791.
  • Mahmood F, Kim H, Chaudary B, et al. Tricuspid annular geometry: a three-dimensional transesophageal echocardiographic study. J Cardiothorac Vasc Anesth. 2013;27(4):639–646.
  • Ton-Nu TT, Levine RA, Handschumacher MD, et al. Geometric determinants of functional tricuspid regurgitation: insights from 3-dimensional echocardiography. Circulation. 2006;114(2):143–149.
  • Irwin RB, Luckie M, Khattar RS. Tricuspid regurgitation: contemporary management of a neglected valvular lesion. Postgrad Med J. 2010;86(1021):648–655.
  • Messer AL, Hurst JW. A study of the venous pulse in tricuspid valve disease. Circulation. 1950;1(3):388–393.
  • Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004;43(3):405–409.
  • Mutlak D, Lessick J, Reisner SA, et al. Echocardiography-based spectrum of severe tricuspid regurgitation: the frequency of apparently idiopathic tricuspid regurgitation. J Am Soc Echocardiogr. 2007;20(4):405–408.
  • Anwar AM, Ten Cate FJ, Soliman OI. Clinical recognition of tricuspid valve disease. In: Soliman OI, Ten Cate FJ, editors. Practical manual of tricuspid valve diseases. Cham: Springer International Publishing; 2018. p. 32–40.
  • Rogers JH, Bolling SF. The tricuspid valve: current perspective and evolving management of tricuspid regurgitation. Circulation. 2009;119(20):2718–2725.
  • Topilsky Y, Khanna A, Le Tourneau T, et al. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension. Circ Cardiovasc Imaging. 2012;5(3):314–323.
  • Utsunomiya H, Itabashi Y, Mihara H, et al. Functional tricuspid regurgitation caused by chronic atrial fibrillation: a real-time 3-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2017;10(1):e004897.
  • Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013;14(7):611–644.
  • Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease). Circulation. 2006;114(5):84–231.
  • Singh JP, Evans JC, Levy D, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83(6): 897–02. DOI:10.1016/S0002-9149(98)01064-9.
  • McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and risk factors for failure. J Thorac Cardiovasc Surg. 2004;127(3):674–685.
  • Wang N, Fulcher J, Abeysuriya N, et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J. 2019;40(5):476–484.
  • Cork DP, McCullough PA, Mehta HS, et al. The economic impact of clinically significant tricuspid regurgitation in a large, administrative claims database. J Med Econ. 2020;23(5):521–528.
  • Dreyfus GD, Martin RP, Chan KM, et al. Functional tricuspid regurgitation: a need to revise our understanding. J Am Coll Cardiol. 2015;65(21): 2331–2336.
  • Desai RR, Vargas Abello LM, Klein AL, et al. Tricuspid regurgitation and right ventricular function after mitral valve surgery with or without concomitant tricuspid valve procedure. J Thorac Cardiovasc Surg. 2013;146(5):1126–1132.
  • Seeburger J, Borger MA, Passage J, et al. Minimally invasive isolated tricuspid valve surgery. J Heart Valve Dis. 2010;34(4):760–765.
  • Vargas Abello LM, Klein AL, Marwick TH, et al. Understanding right ventricular dysfunction and functional tricuspid regurgitation accompanying mitral valve disease. J Thorac Cardiovasc Surg. 2012;145(5):1234–1241.
  • Rivera JM, Vandervoort PM, Vazquez de Prada JA, et al. Which physical factors determine tricuspid regurgitation jet area in the clinical setting? Am J Cardiol. 1993;72(17):1305–1309.
  • Hahn RT, Zamorano JL. The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging. 2017;18(12):1342–1343.
  • Hahn RT, Meduri CU, Davidson CJ, et al. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. J Am Coll Cardiol. 2017;69(14):1795–1796.
  • Miura M, Alessandrini H, Alkhodair A, et al. Impact of massive or torrential tricuspid regurgitation in patients undergoing transcatheter tricuspid valve intervention. JACC Cardiovasc Interv. 2020;13(17): 1999–09. DOI:10.1016/j.jcin.2020.05.011
  • Bartko PE, Arfsten H, Frey MK, et al. Natural history of functional tricuspid regurgitation: implications of quantitative Doppler assessment. JACC Cardiovasc Imaging. 2029;12(3):389–397.
  • Braunwald NS, Ross J Jr, Morrow AG. Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement. Circulation. 1967;35(4 Suppl):I63–9.
  • Chikwe J, Itagaki S, Anyanwu A, et al. Impact of concomitant tricuspid Annuloplasty on tricuspid regurgitation, right ventricular function, and pulmonary artery hypertension after repair of mitral valve prolapse. J Am Coll Cardiol. 2015;65(18):1931–1938.
  • Agarwal S, Tuzcu EM, Rodriguez ER, et al. Interventional cardiology perspective of functional tricuspid regurgitation. Circ Cardiovasc Interv. 2010;2(6):565–573.
  • Izumi C. Isolated functional tricuspid regurgitation: when should we go to surgical treatment? J Cardiol. 2020;75(4):339–343.
  • Hamandi M, George TJ, Smith RL, et al. Current outcomes of tricuspid valve surgery. Prog Cardiovasc Dis. 2019;62(6):463–466.
  • Dreyfus J, Ghalem N, Garbarz E, et al. Timing of referral of patients with severe isolated tricuspid valve regurgitation to surgeons (from a French Nationwide Database). Am J Cardiol. 2018;122(2):323–326.
  • Fender EA, Zack CJ, Nishimura RA. Isolated tricuspid regurgitation: outcomes and therapeutic interventions. Heart. 2018;104(10): 798–06.
  • Zack CJ, Fender EA, Chandrashekar P, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol. 2017;70(24):2953–2960.
  • Kilic A, Saha-Chaudhuri P, Rankin JS, et al. Trends and outcomes of tricuspid valve surgery in North America: an analysis of more than 50,000 patients from the Society of Thoracic Surgeons database. Ann Thorac Surg. 2013;96(5):1546–1552.
  • Dreyfus GD, Corbi PJ, Chan KM, et al. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg. 2005;79(1):127–132.
  • Weir WB, Romano MA, Bolling SF. Current surgical treatment and outcomes for functional tricuspid regurgitation. Structural Heart. 2018;2(2): 96–01.
  • Brescia AA, Ward ST, Watt TMF, et al. Outcomes of guideline-directed concomitant annuloplasty for functional tricuspid regurgitation. Ann Thorac Surg. 2020;109(4):1227–1232.
  • Benedetto U, Melina G, Angeloni E, et al. Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery. J Thorac Cardiovasc Surg. 2012;143(3):632–638.
  • Pettinari M, De Kerchove L, Lazam S, et al. Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery. Eur J Cardiothorac Surg. 2019;55(5):851–858.
  • Cao JY, Wales KM, Zhao DF, et al. Repair of less than severe tricuspid regurgitation during left-sided valve surgery: a meta-analysis. Ann Thorac Surg. 2020;109(3):950–958.
  • Lee JW, Song JM, Park JP, et al. Long-term prognosis of isolated significant tricuspid regurgitation. Circ J. 2010;74(2):375–380.
  • Axtell AL, Bhambhani V, Moonsamy P, et al. Surgery does not improve survival in patients with isolated severe tricuspid regurgitation. J Am Coll Cardiol. 2019;74(6):715–725.
  • Kim JB, Jung SH, Choo SJ, et al. Surgical outcomes of severe tricuspid regurgitation: predictors of adverse clinical outcomes. Heart. 2013;99(3):181–187.
  • Ghanta RK, Chen R, Narayanasamy N, et al. Suture bicuspidization of the tricuspid valve versus ring annuloplasty for repair of functional tricuspid regurgitation: midterm results of 237 consecutive patients. J Thorac Cardiovasc Surg. 2007;133(1):117–126.
  • LaPar DJ, Likosky DS, Zhang M, et al. Development of a risk prediction model and clinical risk score for isolated tricuspid valve surgery. Ann Thorac Surg. 2018;106(1):129–136.
  • Alfieri O, De Bonis M. Tricuspid valve surgery for severe tricuspid regurgitation. Heart. 2013;99(3):149–150.
  • Shinn SH, Schaff HV. Evidence-based surgical management of acquired tricuspid valve disease. Nat Rev Cardiol. 2013;10(4):190–203.
  • Raja SG, Dreyfus GD. Basis for intervention on functional tricuspid regurgitation. Semin Thorac Cardiovasc Surg. 2010;22(1):79–83.
  • Hwang HY, Kim KH, Kim KB, et al. Mechanical tricuspid valve replacement is not superior in patients younger than 65 years who need long-term anticoagulation. Ann Thorac Surg. 2012;93(4):1154–1160.
  • Antunes MJ, Rodriguez-Palomares J, Prendergast B, et al. Management of tricuspid valve regurgitation: position statement of the European Society of Cardiology Working Groups of cardiovascular surgery and valvular heart disease. Eur J Cardiothorac Surg. 2017;52(6):1022–1030.
  • Ohata T, Kigawa I, Tohda E, et al. Comparison of durability of bioprostheses in tricuspid and mitral positions. Ann Thorac Surg. 2001;71(5):240–243.
  • Liu P, Qiao WH, Sun FQ, et al. Should a mechanical or biological prosthesis be used for a tricuspid valve replacement? A meta-analysis. J Card Surg. 2016;31(5): 294–02. DOI:10.1111/jocs.12730
  • De Bonis M, Taramasso M, Lapenna E, et al. Management of tricuspid regurgitation. F1000Prime Rep. 2014;6:58.
  • Fukuda S, Gillinov AM, McCarthy PM, et al. Echocardiographic follow-up of tricuspid annuloplasty with a new three-dimensional ring in patients with functional tricuspid regurgitation. J Am Soc Echocardiogr. 2007;20(11):1236–1242.
  • Dreyfus GD, Raja SG, John Chan KM. Tricuspid leaflet augmentation to address severe tethering in functional tricuspid regurgitation. Eur J Cardiothorac Surg. 2008;34(4):908–910.
  • Lapenna E, De Bonis M, Verzini A, et al. The clover technique for the treatment of complex tricuspid valve insufficiency: midterm clinical and echocardiographic results in 66 patients. Eur J Cardiothorac Surg. 2010;37(6):1297–1303.
  • Taramasso M, Vanermen H, Maisano F, et al. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol. 2012;59(8):703–710.
  • Tang GH, David TE, Singh SK, et al. Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation. 2006;114(1):577–581.
  • Chikwe J, Anyanwu AC. Surgical strategies for functional tricuspid regurgitation. Semin Thorac Cardiovasc Surg. 2010;22(1):90–96.
  • Chikwe J, Dominick Megna. Rationale and surgical strategy for concomitant tricuspid repair. JTCVS Open. 2020;(3):52–61.
  • Kay JH, Maselli-Campagna G, Tsuji HK. Surgical treatment of tricuspid insufficiency. Ann Surg. 1965;162(1):53–58.
  • Mangieri A, Montalto C, Pagnesi M, et al. Mechanism and implications of the tricuspid regurgitation: from the pathophysiology to the current and future therapeutic options. Circ Cardiovasc Interv. 2017;10(7):e005043.
  • De Vega NG. Selective, adjustable and permanent annuloplasty. an original technic for the treatment of tricuspid insufficiency. Rev Esp Cardiol. 1962;25(6):555–556.
  • Antunes MJ, Girdwood RW. Tricuspid annuloplasty: a modified technique. Ann Thorac Surg. 1983 Jun;35(6):676–678.
  • Carpentier A, Deloche A, Dauptain J, et al. A new reconstructive operation for correction of mitral and tricuspid valve disease. J Thorac Cardiovasc Surg. 1971;61(1):1–13.
  • Sohn SH, Kim KH, Lee Y, et al. Long-term outcomes of rigid ring versus De Vega annuloplasty for functional tricuspid regurgitation: A propensity score-matching analysis. J Thorac Cardiovasc Surg. 2019;S0022-5223(19):33963-7.
  • Rivera R, Duran E, Ajuria M. Carpentier’s flexible ring versus De Vega’s annuloplasty. A prospective randomized study. J Thorac Cardiovasc Surg. 1985;89(2): 196–03.
  • Murashita T, Okada Y, Kanemitsu H, et al. Long-term outcomes of tricuspid annuloplasty for functional tricuspid regurgitation associated with degenerative mitral regurgitation: suture annuloplasty versus ring annuloplasty using a flexible band. Ann Thorac Cardiovasc Surg. 2014;20(6):1026–1033.
  • Pfannmuller B, Doenst T, Eberhardt K, et al. Increased risk of dehiscence after tricuspid valve repair with rigid annuloplasty rings. J Thorac Cardiovasc Surg. 2012;143(5):1050–1055.
  • Belluschi I, Del Forno B, Lapenna E, et al. Surgical techniques for tricuspid valve disease. Front Cardiovasc Med. 2018;5:118.
  • Taramasso M, Benfari G, van der Bijl P, et al. Transcatheter versus medical treatment of patients with symptomatic severe tricuspid regurgitation. J Am Coll Cardiol. 2019;74(24): 2998–08. DOI:10.1016/j.jacc.2019.09.028.
  • Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–1486.
  • Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44): 3075–28.
  • Akinosoglou K, Apostolakis E, Koutsogiannis N, et al. Right-sided infective endocarditis: surgical management. Eur J Cardiothorac Surg. 2012;42(3):470–479.
  • Slaughter MS, Badhwar V, Ising M, et al. Optimum surgical treatment for tricuspid valve infective endocarditis: an analysis of the society of thoracic surgeons national database. J Thorac Cardiovasc Surg. 2019;S0022-5223(19): 32516–4.
  • Protos AN, Trivedi JR, Whited WM, et al. Valvectomy versus replacement for the surgical treatment of tricuspid endocarditis. Ann Thorac Surg. 2018;106(3):664–669.
  • Wallen TJ, Szeto W, Williams M, et al. Tricuspid valve endocarditis in the era of the opioid epidemic. J Card Surg. 2018;33(5):260–264.
  • Grossi EA, Galloway AC, LaPietra A, et al. Minimally invasive mitral valve surgery: a 6-year experience with 714 patients. Ann Thorac Surg. 2002;74(3):660–664.
  • Modi P, Hassan A, Chitwood WR Jr. Minimally invasive mitral valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2008;34(5):943–952.
  • Seeburger J, Borger MA, Falk V, et al. Minimal invasive mitral valve repair for mitral regurgitation: results of 1339 consecutive patients. Eur J Cardiothorac Surg. 2008;34(4):760–765.
  • Ricci D, Boffini M, Barbero C, et al. Minimally invasive tricuspid valve surgery in patients at high risk. J Thorac Cardiovasc Surg. 2014;147(3): 996–01. DOI:10.1016/j.jtcvs.2013.03.018
  • Tagliari AP, Taramasso M. Transcatheter tricuspid interventions: time to re-think guidelines? Aging (Albany NY). 2020;12(2):1037–1038.
  • Taramasso M, Alessandrini H, Latib A, et al. Outcomes after current transcatheter tricuspid valve intervention: mid-term results from the international trivalve registry. JACC Cardiovasc Interv. 2019;12(2):155–165.
  • Chang CC, Veen KM, Hahn RT, et al. Uncertainties and challenges in surgical and transcatheter tricuspid valve therapy: a state-of-the-art expert review. Eur Heart J. 2020;41(20):1932–1940.
  • Asmarats L, Puri R, Latib A, et al. Transcatheter tricuspid valve interventions: landscape, challenges, and future directions. J Am Coll Cardiol. 2018;71(25):2935–2956.
  • Nickenig G, Kowalski M, Hausleiter J, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique. Circulation. 2017;135(19):1802–1814.
  • Nickenig G, Weber M, Lurz P, et al. Transcatheter edge-to-edge repair for reduction of tricuspid regurgitation: 6-month outcomes of the TRILUMINATE single-arm study. Lancet. 2019;394(10213):2002–2011.
  • Lurz P, on behalf of the TRILUMINATE investigators. Percutaneous edge-to-edge repair for tricuspid regurgitation: 1-year outcomes from the TRILUMINATE trial. Presented at: PCR e-course. 2020.
  • Davidson C, Lim S, Smith R. Early feasibility study of Cardioband tricuspid system for functional tricuspid regurgitation: 30-day outcomes. JACC. 2020;75:1132.
  • Nickenig G, Weber M, Schüler R, et al. Two-year outcomes with the cardioband tricuspid system from the multicentre, prospective TRI-REPAIR Study. EuroIntervention. 2020;13:EIJ-D-20-01107.
  • Fam NP, Braun D, von Bardeleben RS, et al. Compassionate Use of the PASCAL transcatheter valve repair system for severe tricuspid regurgitation: a multicenter, observational, first-in-human experience. JACC Cardiovasc Interv. 2019;12(24):2488–2495.
  • Sanon S, Cabalka AK, Babaliaros V, et al. Transcatheter tricuspid valve-in-valve and valve-in-ring implantation for degenerated surgical prosthesis. JACC Cardiovasc Interv. 2019;12(15):1403–1412.
  • McElhinney DB, Aboulhosn JA, Dvir D, et al. Mid-term valve-related outcomes after transcatheter tricuspid valve-in-valve or valve-in-ring replacement. J Am Coll Cardiol. 2019;73(2):148–157.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.